Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Sep-24 9:20 PM View:  | Viking Therapeutics, Inc. (VKTX) | 20-Sep-24 | Option Exercise | 166,130 | $7.77 | $1,290,830.00 | 7% 2.35M to 2.52M | |
| 20-Sep-24 9:20 PM View: | Viking Therapeutics, Inc. (VKTX) | 20-Sep-24 | Planned Option Sale | 166,130 | $70.83 | $11,767,000.00 | (7%) 2.52M to 2.35M | |
| 20-Sep-24 9:20 PM View: | Viking Therapeutics, Inc. (VKTX) | 20-Sep-24 | Sale (Planned) | 50,000 | $70.83 | $3,541,520.00 | (2%) 2.35M to 2.3M | |
| 22-Aug-24 7:23 PM View: | Viking Therapeutics, Inc. (VKTX) | 21-Aug-24 | Option Exercise | 1,000 | $7.77 | $7,770.00 | < 1% 2.35M to 2.36M | |
| 22-Aug-24 7:23 PM View: | Viking Therapeutics, Inc. (VKTX) | 21-Aug-24 | Planned Option Sale | 1,000 | $69.90 | $69,900.00 | (< 1%) 2.36M to 2.35M | |
| 31-Jul-24 4:05 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Jul-24 | Sale | 115,859 | $57.58 | $6,670,600.00 | (5%) 2.47M to 2.35M | |
| 31-Jul-24 4:05 PM View: | Viking Therapeutics, Inc. (VKTX) | 29-Jul-24 | Grant | 204,333 | -- | -- | 9% 2.27M to 2.47M | |
| 27-Mar-24 8:51 PM View: | Viking Therapeutics, Inc. (VKTX) | 27-Mar-24 | Grant | 221,667 | -- | -- | 10% 2.2M to 2.42M | |
| 27-Mar-24 8:51 PM View: | Viking Therapeutics, Inc. (VKTX) | 27-Mar-24 | Payment of Exercise | 153,948 | $83.34 | $12,830,000.00 | (6%) 2.42M to 2.27M | |
| 04-Mar-24 7:54 PM View: | Viking Therapeutics, Inc. (VKTX) | 01-Mar-24 | Grant | 221,667 | -- | -- | 10% 2.14M to 2.36M | |
| 04-Mar-24 7:54 PM View: | Viking Therapeutics, Inc. (VKTX) | 01-Mar-24 | Payment of Exercise | 162,815 | $85.22 | $13,875,100.00 | (7%) 2.36M to 2.2M | |
| 09-Feb-24 8:59 PM View: | Viking Therapeutics, Inc. (VKTX) | 09-Feb-24 | Private Sale (Planned) | 45,000 | $29.90 | $1,345,500.00 | (2%) 2.18M to 2.14M | |
| 08-Feb-24 7:40 PM View: | Viking Therapeutics, Inc. (VKTX) | 08-Feb-24 | Option Exercise | 189,079 | $3.76 | $711,367.00 | 8% 2.26M to 2.45M | |
| 08-Feb-24 7:40 PM View: | Viking Therapeutics, Inc. (VKTX) | 08-Feb-24 | Planned Option Sale | 189,079 | $26.87 | $5,081,000.00 | (8%) 2.45M to 2.26M | |
| 08-Feb-24 7:40 PM View: | Viking Therapeutics, Inc. (VKTX) | 08-Feb-24 | Sale (Planned) | 80,000 | $26.87 | $2,149,790.00 | (4%) 2.26M to 2.18M | |
| 31-Jan-24 8:39 PM View: | Viking Therapeutics, Inc. (VKTX) | 31-Jan-24 | Option Exercise | 85,000 | $1.23 | $104,550.00 | 4% 2.26M to 2.35M | |
| 31-Jan-24 8:39 PM View: | Viking Therapeutics, Inc. (VKTX) | 31-Jan-24 | Planned Option Sale | 85,000 | $24.71 | $2,100,750.00 | (4%) 2.35M to 2.26M | |
| 30-Jan-24 9:05 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Jan-24 | Option Exercise | 35,000 | $1.23 | $43,050.00 | 2% 2.26M to 2.3M | |
| 30-Jan-24 9:05 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Jan-24 | Planned Option Sale | 35,000 | $23.95 | $838,250.00 | (2%) 2.3M to 2.26M | |
| 04-Jan-24 9:37 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-24 | Payment of Exercise | 39,552 | $18.58 | $734,876.00 | (2%) 2.3M to 2.26M | |
| 04-Jan-24 9:37 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-24 | Grant | 310,000 | -- | -- | 14% 2.21M to 2.52M | |
| 04-Jan-24 9:37 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-24 | Payment of Exercise | 214,640 | $17.40 | $3,734,740.00 | (9%) 2.52M to 2.3M | |
| 01-May-23 10:00 PM View: | Viking Therapeutics, Inc. (VKTX) | 01-May-23 | Private Sale (Planned) | 45,000 | $22.45 | $1,010,250.00 | (2%) 2.24M to 2.2M | |
| 21-Apr-23 7:29 PM View: | Viking Therapeutics, Inc. (VKTX) | 19-Apr-23 | Private Sale (Planned) | 35,000 | $21.45 | $750,750.00 | (2%) 2.28M to 2.24M | |
| 18-Apr-23 7:09 PM View: | Viking Therapeutics, Inc. (VKTX) | 17-Apr-23 | Option Exercise | 125,000 | $2.15 | $268,750.00 | 5% 2.31M to 2.43M | |
| 18-Apr-23 7:09 PM View: | Viking Therapeutics, Inc. (VKTX) | 17-Apr-23 | Planned Option Sale | 125,000 | $20.45 | $2,556,260.00 | (5%) 2.43M to 2.31M | |
| 18-Apr-23 7:09 PM View: | Viking Therapeutics, Inc. (VKTX) | 17-Apr-23 | Sale (Planned) | 30,000 | $20.45 | $613,503.00 | (1%) 2.31M to 2.28M | |
| 13-Apr-23 5:14 PM View: | Viking Therapeutics, Inc. (VKTX) | 13-Apr-23 | Option Exercise | 54,336 | $1.88 | $102,152.00 | 2% 2.33M to 2.39M | |
| 13-Apr-23 5:14 PM View: | Viking Therapeutics, Inc. (VKTX) | 13-Apr-23 | Planned Option Sale | 54,336 | $18.45 | $1,002,500.00 | (2%) 2.39M to 2.33M | |
| 13-Apr-23 5:14 PM View: | Viking Therapeutics, Inc. (VKTX) | 13-Apr-23 | Sale (Planned) | 25,000 | $18.45 | $461,250.00 | (1%) 2.33M to 2.31M | |
| 03-Apr-23 7:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Apr-23 | Grant | 300,000 | -- | -- | 13% 2.25M to 2.55M | |
| 03-Apr-23 7:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Apr-23 | Payment of Exercise | 200,000 | $17.57 | $3,514,000.00 | (8%) 2.55M to 2.35M | |
| 03-Apr-23 7:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Apr-23 | Sale (Planned) | 22,000 | $17.85 | $392,700.00 | (< 1%) 2.35M to 2.33M | |
| 03-Apr-23 7:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 31-Mar-23 | Option Exercise | 67,970 | $9.49 | $645,035.00 | 3% 2.25M to 2.32M | |
| 03-Apr-23 7:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 31-Mar-23 | Planned Option Sale | 49,970 | $17.45 | $871,977.00 | (2%) 2.32M to 2.27M | |
| 03-Apr-23 7:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 31-Mar-23 | Sale (Planned) | 18,000 | $17.45 | $314,100.00 | (< 1%) 2.27M to 2.25M | |
| 03-Apr-23 7:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Mar-23 | Option Exercise | 135,382 | $2.42 | $327,838.00 | 6% 2.27M to 2.41M | |
| 03-Apr-23 7:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Mar-23 | Planned Option Sale | 153,382 | $17.16 | $2,632,520.00 | (6%) 2.41M to 2.25M | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-23 | Payment of Exercise | 28,619 | $8.42 | $240,972.00 | (1%) 2.3M to 2.27M | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-23 | Grant | 266,667 | -- | -- | 13% 2.1M to 2.37M | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-23 | Payment of Exercise | 68,252 | $8.52 | $581,507.00 | (3%) 2.37M to 2.3M | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Dec-22 | Grant | 121,667 | -- | -- | 6% 2.05M to 2.17M | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Dec-22 | Payment of Exercise | 66,127 | $9.40 | $621,594.00 | (3%) 2.17M to 2.1M | |
| 05-Jan-22 7:12 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-22 | Payment of Exercise | 26,432 | $4.62 | $122,116.00 | (1%) 2.06M to 2.04M | |
| 05-Jan-22 7:12 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-22 | Grant | 173,333 | -- | -- | 9% 1.93M to 2.1M | |
| 05-Jan-22 7:12 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-22 | Payment of Exercise | 36,319 | $4.88 | $177,237.00 | (2%) 2.1M to 2.06M | |
| 30-Sep-21 5:48 PM View: | Viking Therapeutics, Inc. (VKTX) | 28-Sep-21 | Grant | 55,500 | -- | -- | 3% 1.9M to 1.95M | |
| 30-Sep-21 5:48 PM View: | Viking Therapeutics, Inc. (VKTX) | 28-Sep-21 | Payment of Exercise | 27,750 | $6.50 | $180,375.00 | (1%) 1.95M to 1.92M | |
| 19-Jan-21 6:19 PM View: | Viking Therapeutics, Inc. (VKTX) | 19-Jan-21 | Payment of Exercise | 5,611 | $6.68 | $37,481.50 | (< 1%) 1.9M to 1.89M | 3% |
| 06-Jan-21 4:34 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-21 | Grant | 204,333 | -- | -- | 12% 1.71M to 1.92M |